The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Revisiting: Holding a dose indefinitely: is there a documented downside?

This is a generated summary. It shows the 5 most-liked posts from a topic of 31, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
M
MakinenTL2Member11 Oct 2024#1

The question in the title: Revisiting: Holding a dose indefinitely: is there a documented downside? I will give what I have already checked below so nobody repeats it.

A question about technique rather than about dose.

I have been doing the same thing for 5 months and it works, and then I read one of the documentation pages here and realised I may have been reasoning from a misunderstanding the whole time. Nothing has gone wrong; I would just like to understand why it has not.

What I do, exactly, is described below. Please tell me which parts are load-bearing and which are superstition.

35 likes 22mo
CC
crossref_checkTL3Wiki editor3 Nov 2024 · edited#5
v.bergstrom, post #2: Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The published trials used a calendar-based schedule. Tolerability-based escalation has no formal evidence base but is not uncommon in practice. Go to post

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

26 likes in reply to #2 21mo
FD
f.danquahTL2 Moderator Solution7 Nov 2024#6

Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that very small increments are hard to measure accurately with a syringe.

12 likes 21mo
EA
e.almeidaTL2Member16 Dec 2024#17
c.okafor, post #7: On post #3 — agreed on the reasoning, with one qualification. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a reasonable response. If the side effect is not dose-dependent (e.g., hypoglycemia with insulin), dose… Go to post

Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that stepping down is followed by some regain, with the magnitude unknown.

30 likes in reply to #7 19mo
M
MSaarinenTL3Regular3 Jan 2025#23
p.krastev, post #4: post #3 is right about the mechanism and I think understates the practical bit. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been studied clinically. One mg of semaglutide is not equivalent to one mg of something else in any… Go to post

Worth separating two things that post #19 runs together.

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

32 likes in reply to #4 19mo

Read the full topic (31 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Holding a dose indefinitely: is there a documented downside?
Holding a dose indefinitely: is there a documented downside? — that is the question, and I have not found it answered plainly anywhere I have looked. A question about technique rather than about dose. I have…
HFOBRSPPBD+28 32 57k 12mo
Why "dose equivalence" between different incretin analogues is a weak concept
Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…
WVERFYWMB+124 133 11k 5mo
Where the four-week escalation interval comes from, and what it is not
On the subject in the title: Where the four-week escalation interval comes from, and what it is not Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I…
CCNWVNRW+56 60 21k 2y
Micro-titration: a disputed topic, argued properly
Micro-titration: a disputed topic, argued properly Writing it up because I had to work it out twice and would rather nobody else did. A question about technique rather than about dose. I have been doing the…
ESKHVKASNP+99 110 61k 2d
Follow-up: The lowest dose that does anything: is that a real question?
The question in the title: The lowest dose that does anything: is that a real question? I will give what I have already checked below so nobody repeats it. I have read the maintained page on this and I still…
SCYAJWEHYM+70 75 12k 8mo

Related topics — sharing the tags titration, tirzepatide, worked example

TopicParticipantsRepliesViewsActivity
Tirzepatide's shorter half-life and its one practical consequence
On the subject in the title: Tirzepatide's shorter half-life and its one practical consequence Working notes rather than a conclusion. I have seen SELECT ( N Engl J Med , 2023) cited in support of a claim I…
RERMNECCB+18 29 20k 8mo
When a dose reduction is the correct response to a side effect — a second dataset
When a dose reduction is the correct response to a side effect — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on…
HSSMMMDPT+10 14 42k 2mo
Why we ask for units every single time, with three examples of what goes wrong — what changed since
The question in the title: Why we ask for units every single time, with three examples of what goes wrong — what changed since I will give what I have already checked below so nobody repeats it. Question in…
BASOBPRCGH+14 18 19k 2mo
The arithmetic of an intermediate dose between two label steps
On the subject in the title: The arithmetic of an intermediate dose between two label steps Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am…
MHJHCB 2 136 2mo
Follow-up: Why the titration planner refuses to produce a schedule below a floor
The question in the title: Why the titration planner refuses to produce a schedule below a floor I will give what I have already checked below so nobody repeats it. I would like to understand what this number…
COCKHCNRM+120 146 14k 10mo